Influencing factors of cognitive frailty in older patients with esophageal cancer undergoing chemotherapy: a mixed-methods study
-
By
-
Fan Wang
-
Zhie Gu
-
Yixin Jia
-
Yuhui Li
-
Quan Mao
-
Yusheng Shu
-
June 16, 2026
-
Clinical Scorecard: Determinants of Cognitive Frailty in Elderly Esophageal Cancer Patients Undergoing Chemotherapy: A Mixed-Methods Investigation
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Revise to include only mechanisms directly supported by the source. |
| Target Population | |
| Care Setting | |
Key Highlights
Guideline-Based Recommendations
Diagnosis
Management
- R
- e
- v
- i
- s
- e
-
- t
- o
-
- i
- n
- c
- l
- u
- d
- e
-
- o
- n
- l
- y
-
- r
- e
- c
- o
- m
- m
- e
- n
- d
- a
- t
- i
- o
- n
- s
-
- d
- i
- r
- e
- c
- t
- l
- y
-
- s
- t
- a
- t
- e
- d
-
- i
- n
-
- t
- h
- e
-
- s
- o
- u
- r
- c
- e
- .
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Older patients with esophageal cancer receiving chemotherapy.
Chemotherapy may exacerbate cognitive frailty due to treatment-related toxicities.
Clinical Best Practices
Related Resources & Content
